Дарья Зайниев - С ума сойти! Путеводитель по психическим расстройствам для жителя большого города

Ryan KA, Dawson EL, Kassel MT, et al. Shared dimensions of performance and activation dysfunction in cognitive control in females with mood disorders. Brain. 2015; 138(Pt 5): 1424–34.

Mackin P, Young AH, The Role of Cortisol and Depression: Exploring New Opportunities for Treatments, Psychiatric Times, 2004; 21: 92–5.

Herbert J. Cortisol and depression: three questions for psychiatry. Psychol Med. 2013; 43(3): 449–69.

Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(22): 12320–12322.

Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. Hay PJ, ed. PLoS Medicine. 2013; 10(11): e1001547.

Соломон Э. Демон полуденный: Анатомия депрессии. — М.: Доб­рая книга, 2004.

Chronic Health Problems among U. S. Adults, by Poverty Status, 2011, Gallup Healthways Well-Being Index.

Jonassen R, Chelnokova O, Harmer C, Leknes S, Landrø NI. A single dose of antidepressant alters eye-gaze patterns across face stimuli in healthy women. Psychopharmacology (Berl). 2015; 232(5): 953–8.

Selikoff IJ, Robitzek EH. Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid. Dis Chest. 1952; 21(4): 385–438.

Burn JH. The Antihistamine Compounds. British Medical Journal. 1958; 2(5100): 845–846.

Pletscher A. The discovery of antidepressants: a winding path. Experientia. 1991; 47(1): 4–8.

Fagius J, Osterman PO, Sidén A, Wiholm BE. Guillain-Barré syndrome following zimeldine treatment. Journal of Neurology, Neurosurgery, and Psychiatry. 1985; 48(1): 65–69.

Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry. 1998; 59 Suppl 15: 42–8.

Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006; 163(1): 41–7.

Dunlop BW, Davis PG. Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review. Primary Care Companion to The Journal of Clinical Psychiatry. 2008; 10(3): 222–228.

Постановление Правительства Российской Федерации от 4 февраля 2013 г. № 78 г. Москвы «О внесении изменений в некоторые акты Правительства Российской Федерации».

Boyce P, Judd F. The place for the tricyclic antidepressants in the treatment of depression. Aust N Z J Psychiatry. 1999; 33(3): 323–7.

Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, Severity, and Comorbidity of Twelve-month DSM–IV Disorders in the National Comorbidity Survey Replication (NCS-R). Archives of general psychiatry. 2005; 62(6): 617–627. doi: 10.1001/archpsyc.62.6.617.

Machado M, Einarson TR. Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials. J Clin Pharm Ther. 2010; 35(2): 177–88.

Nieuwstraten CE, Dolovich LR. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression. Ann Pharmacother. 2001; 35(12): 1608–13.

Pagnin D, De queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004; 20(1): 13–20.

Beltman MW, Voshaar RC, Speckens AE. Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br J Psychiatry. 2010; 197(1): 11–9.

Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008; 69(4): 621–32.

U. S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health. (2015). Mental Health Information: Depression. Retrieved from http://www.nimh.nih.gov/health/topics/depression/index.shtml.

Manber R, Kraemer HC, Arnow BA, et al. Faster Remission of Chronic Depression With Combined Psychotherapy and Medication Than With Each Therapy Alone. Journal of consulting and clinical psychology. 2008; 76(3): 459–467. doi: 10.1037/0022–006X.76.3.459.

Lemmens LH, Arntz A, Peeters F, Hollon SD, Roefs A, Huibers MJ. Clinical effectiveness of cognitive therapy v. interpersonal psychotherapy for depression: results of a randomized controlled trial. Psychol Med. 2015; 45(10): 2095–110.

Goodwin FK, Jamison KR. Manic-depressive illness: bipolar disorders and recurrent depression. 2. New York: Oxford University Press; 2007.

Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord. 2003; 73(1–2): 123–31.

Roccatagliata G. A History of Ancient Psychiatry. Praeger Pub Text; 1986. (pp. 230–231).

Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry. 2010; 67(4): 339–47.

Jamison KR. An Unquiet Mind, A Memoir of Moods and Madness. Vintage; 2009, p. 36.

Jamison KR. Suicide and Bipolar Disorder. J Clin Psychiatry 2000; 61 (Suppl 9): 47–51.

Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry. 2010; 67(4): 339–47.

Kerner B. Genetics of bipolar disorder. The Application of Clinical Genetics. 2014; 7: 33–42. doi: 10.2147/TACG.S39297.

Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013; 381(9875): 1371–9.

Stein DJ, Kupfer DJ, Schatzberg AF. The American Psychiatric Publishing Textbook of Mood Disorders. American Psychiatric Pub; 2007: 159–75.

Siegel D. Mindsight, Transform Your Brain with the New Science of Kindness. Oneworld Publications; 2010: 80–101.

J. R. Whitwell, Historical Notes on Psychiatry. London: Lewis, 1936.

Andreasen NC. The relationship between creativity and mood disorders. Dialogues in Clinical Neuroscience. 2008; 10(2): 251–255.

Jamison KR. Mood disorders and patterns of creativity in British writers and artists. Psychiatry. 1989; 52(2): 125–34.

Ludwig AM. Creative achievement and psychopathology: comparison among professions. Am J Psychother. 1992; 46(3): 330–56.

Santosa CM, Strong CM, Nowakowska C, Wang PW, Rennicke CM, Ketter TA. Enhanced creativity in bipolar disorder patients: a controlled study. J Affect Disord. 2007; 100(1–3): 31–9.

Kyaga S, Lichtenstein P, Boman M, Hultman C, Långström N, Landén M. Creativity and mental disorder: family study of 300,000 people with severe mental disorder. Br J Psychiatry. 2011;199(5): 373–9.

Frederick K. Googwin, Kay Redfield Jamison. Manic-depressive ilness. Bipolar disorders and reccurent depression. Oxford University Press 2007.

Figueroa c G. [Virginia Woolf as an example of a mental disorder and artistic creativity]. Rev Med Chil. 2005; 133(11): 1381–8.

Ta-Wei Guu, Kuan-Pin Su. Musical creativity and mood bipolarity in Robert Schumann: A tribute on the 200th anniversary of the composer's birth. Psychiatry and Clinical Neurosciences 2011; 65: 112–114.

Stephen G. Michaud, Hugh Aynesworth. The Only Living Witness: The True Story of Serial Sex Killer Ted Bundy.

M. Fink, Delirious mania. Bipolar Disorders, vol. 1, no. 1, pp. 54–60, 1999.

Fazel S, Lichtenstein P, Grann M, Goodwin GM, Långström N. Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Arch Gen Psychiatry. 2010;67(9): 931–8.

https://www.psychologytoday.com/blog/inside-the-criminal-mind/ 201105/bipolar-illness-or-the-ups-and-downs-the-antisocial-persons

Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?. J Affect Disord. 1999; 52(1–3): 135–44.

Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders. The American journal of psychiatry. 2013; 170(11): 1249–1262. doi: 10.1176/appi.ajp.2013.13020185.

Tohen M, Zarate CA, Hennen J, et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry. 2003; 160(12): 2099–107.

Simhandl C, König B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014; 75(3): 254–62.

Baethge C, Baldessarini RJ, Mathiske-schmidt K, et al. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients. J Clin Psychiatry. 2005; 66(2): 174–82.

Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014; 2: 15. doi: 10.1186/s40345–014–0015–8.

Van der loos ML, Kölling P, Knoppert-van der klein EA, Nolen WA. [Lamotrigine in the treatment of bipolar disorder, a review]. Tijdschr Psychiatr. 2007; 49(2): 95–103.

Rapoport SI, Basselin M, Kim HW, Rao JS. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009; 61(2): 185–209.

Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052.

Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194(1): 4–9.

Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. International Journal of Bipolar Disorders. 2014;2:15. doi: 10.1186/s40345–014–0015–8.

Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009; 194 (1): 4–9.

Macritchie K, Geddes JR, Scott J, Haslam D, De lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003; (1): CD004052.

Ushkalova AV, Kostiukova EG, Mosolov SN. [A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder]. Zh Nevrol Psikhiatr Im S S Korsakova. 2015; 115(1 Vypusk 2 Depressiia): 23–30.

Zaretsky AE, Rizvi S, Parikh SV. How well do psychosocial interventions work in bipolar disorder?. Can J Psychiatry. 2007;5 2(1): 14–21.

Frank E, Swartz HA, Mallinger AG, Thase ME, Weaver EV, Kupfer DJ. Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol. 1999;108(4): 579–87.

Miklowitz DJ. The Bipolar Disorder Survival Guide, Second Edition, What You and Your Family Need to Know. Guilford Press; 2011.

Braga RJ, Burdick KE, Derosse P, Malhotra AK. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012; 200(2–3):242–5.

Steimer T. The biology of fear- and anxiety-related behaviors. Dialogues in Clinical Neuroscience. 2002; 4(3): 231–249.

Ohman A, Lundqvist D, Esteves F. The face in the crowd revisited: a threat advantage with schematic stimuli. J Pers Soc Psychol. 2001; 80 (3): 381–96.

Pittman CM, Karle EM. Rewire Your Anxious Brain, How to Use the Neuroscience of Fear to End Anxiety, Panic, and Worry. New Harbinger Publications Incorporated; 2014:16–24.